Knoop C et al. |
FK 506 rescue therapy for irreversible airway rejection in heart-lung transplant recipients: report on five cases. |
1994 |
Transplant. Proc. |
pmid:7527957
|
Guy S et al. |
Immunosuppression conversion for relief of side effects. |
1994 |
Transplant. Proc. |
pmid:7527956
|
Hara Y et al. |
Unresponsiveness to rat cardiac allografts induced by intrathymic injection of donor bone marrow cells and short course of immunosuppression. |
1994 |
Transplant. Proc. |
pmid:7527955
|
Meiser BM and Reichart B |
New trends in clinical immunosuppression. |
1994 |
Transplant. Proc. |
pmid:7527954
|
Christe W |
Neurological disorders in liver and kidney transplant recipients. |
1994 |
Transplant. Proc. |
pmid:7527953
|
Platz KP et al. |
Causes of death following liver transplantation in FK 506- and cyclosporine-treated patients. |
1994 |
Transplant. Proc. |
pmid:7527952
|
Mueller AR et al. |
Severe neurotoxicity after liver transplantation: association between FK 506 therapy and hepatitis C virus disease. |
1994 |
Transplant. Proc. |
pmid:7527951
|
Mathieu C et al. |
Potential role of 1,25(OH)2 vitamin D3 as a dose-reducing agent for cyclosporine and FK 506. |
1994 |
Transplant. Proc. |
pmid:7527950
|
Gaweco AS et al. |
Distinct intragraft cytokine gene expression patterns during acute hepatic rejection under cyclosporine versus FK 506 primary immunosuppression. |
1994 |
Transplant. Proc. |
pmid:7527948
|
Fisher A et al. |
Gastrointestinal toxicity associated with FK 506 in liver transplant recipients. |
1994 |
Transplant. Proc. |
pmid:7527947
|
Nielsen FT et al. |
Nephrotoxity of FK 506: a preliminary study on comparative aspects of FK 506 and cyclosporine nephrotoxicity. |
1994 |
Transplant. Proc. |
pmid:7527946
|
Lea JP et al. |
Evidence that the inhibition of Na+/K(+)-ATPase activity by FK506 involves calcineurin. |
1994 |
Kidney Int. |
pmid:7527873
|
Cooper MH et al. |
Short-term myeloid reconstitution following TBI is not adversely affected by doses of FK506 that abrogate lethal GVHD. |
1994 |
Bone Marrow Transplant. |
pmid:7527689
|
Abdalla AH et al. |
FK 506 as an alternative in cyclosporin-induced hemolytic uremic syndrome in a kidney transplant recipient. |
1994 |
Transpl. Int. |
pmid:7527640
|
Stark JH et al. |
Sensitivity of baboon lymphocytes to cyclosporin A and FK 506: relative resistance of alloactivated cells to CyA. |
1994 |
Transpl. Int. |
pmid:7527639
|
Winkler M et al. |
The use of plasma levels for FK 506 dosing in liver-grafted patients. |
1994 |
Transpl. Int. |
pmid:7527638
|
Jiang H et al. |
The superior effect of the combination of FK 506 and deoxyspergualin on rat cardiac allograft survival. |
1994 |
Transpl. Int. |
pmid:7527637
|
Calmus Y |
[Rejection of a liver allograft. Diagnosis and treatment]. |
1994 |
Ann Radiol (Paris) |
pmid:7527621
|
Chen SR et al. |
Asymmetrical blockade of the Ca2+ release channel (ryanodine receptor) by 12-kDa FK506 binding protein. |
1994 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:7527548
|
Lewis HM |
Therapeutic progress. II: Treatment of psoriasis. |
1994 |
J Clin Pharm Ther |
pmid:7527403
|
Winkler M et al. |
Plasma vs whole blood for therapeutic drug monitoring of patients receiving FK 506 for immunosuppression. |
1994 |
Clin. Chem. |
pmid:7527306
|
Shaw LM and Brayman KL |
FK-506 therapeutic drug monitoring. |
1994 |
Clin. Chem. |
pmid:7527305
|
Rosenwirth B et al. |
Inhibition of human immunodeficiency virus type 1 replication by SDZ NIM 811, a nonimmunosuppressive cyclosporine analog. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7527198
|
Alnemri ES et al. |
FKBP46, a novel Sf9 insect cell nuclear immunophilin that forms a protein-kinase complex. |
1994 |
J. Biol. Chem. |
pmid:7527037
|
Lemoine A et al. |
FK 506 renal toxicity and lack of detectable cytochrome P-450 3A in the liver graft of a patient undergoing liver transplantation. |
1994 |
Hepatology |
pmid:7527003
|
Akamine S et al. |
Monitoring canine lung allograft rejection using Ia antigen expression by bronchoalveolar lymphocytes. |
1994 |
Surg. Today |
pmid:7526914
|
Bush KT et al. |
Induction of the FK506-binding protein, FKBP13, under conditions which misfold proteins in the endoplasmic reticulum. |
1994 |
Biochem. J. |
pmid:7526846
|
Lauerma AI et al. |
Topical FK506: suppression of allergic and irritant contact dermatitis in the guinea pig. |
1994 |
Arch. Dermatol. Res. |
pmid:7526805
|
Carroll PB et al. |
Effect of tacrolimus (FK506) in dystrophic epidermolysis bullosa: rationale and preliminary results. |
1994 |
Arch Dermatol |
pmid:7526802
|
Ishioka M et al. |
FK506 treatment of noninfectious uveitis. |
1994 |
Am. J. Ophthalmol. |
pmid:7526689
|
Holländer GA et al. |
Disruption of T cell development and repertoire selection by calcineurin inhibition in vivo. |
1994 |
Transplantation |
pmid:7526495
|
Ko S et al. |
The pharmacokinetic benefits of newly developed liposome-incorporated FK506. |
1994 |
Transplantation |
pmid:7526494
|
Radanyi C et al. |
The ability of the immunophilin FKBP59-HBI to interact with the 90-kDa heat shock protein is encoded by its tetratricopeptide repeat domain. |
1994 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:7526392
|
Connolly JO et al. |
Renal arteriopathy associated with FK 506 therapy following liver transplantation. |
1994 |
Nephrol. Dial. Transplant. |
pmid:7526278
|
Cullen BR and Heitman J |
Human immunodeficiency virus. Chaperoning a pathogen. |
1994 |
Nature |
pmid:7526224
|
Kinoshita I et al. |
Very efficient myoblast allotransplantation in mice under FK506 immunosuppression. |
1994 |
Muscle Nerve |
pmid:7526208
|
Hacker J and Fischer G |
Immunophilins: structure-function relationship and possible role in microbial pathogenicity. |
1993 |
Mol. Microbiol. |
pmid:7526121
|
Hiromatsu Y et al. |
Inhibitory effect of FK506 on intercellular adhesion molecule-1 (ICAM-1) expression on cultured thyroid cells. |
1994 |
Kurume Med J |
pmid:7526029
|
Mukaida N et al. |
Molecular mechanism of interleukin-8 gene expression. |
1994 |
J. Leukoc. Biol. |
pmid:7525815
|
Funk JO and Maibach HI |
Horizons in pharmacologic intervention in allergic contact dermatitis. |
1994 |
J. Am. Acad. Dermatol. |
pmid:7525668
|
Gruber SA et al. |
Pharmacokinetics of FK506 after intravenous and oral administration in patients awaiting renal transplantation. |
1994 |
J Clin Pharmacol |
pmid:7525661
|
Benton BM et al. |
A novel FK506- and rapamycin-binding protein (FPR3 gene product) in the yeast Saccharomyces cerevisiae is a proline rotamase localized to the nucleolus. |
1994 |
J. Cell Biol. |
pmid:7525596
|
Shafiee A et al. |
Enzymology of FK-506 biosynthesis. Purification and characterization of 31-O-desmethylFK-506 O:methyltransferase from Streptomyces sp. MA6858. |
1994 |
Eur. J. Biochem. |
pmid:7525282
|
Tamir H et al. |
Secretogogue-induced gating of chloride channels in the secretory vesicles of parafollicular cells. |
1994 |
Endocrinology |
pmid:7525261
|
Milan D et al. |
The latch region of calcineurin B is involved in both immunosuppressant-immunophilin complex docking and phosphatase activation. |
1994 |
Cell |
pmid:7525078
|
Papaccio G et al. |
The immunosuppressant FK506 inhibits the damage to mouse pancreatic islets induced by low dose streptozocin. |
1994 |
Cell Tissue Res. |
pmid:7525068
|
von Asmuth EJ et al. |
IL-6, IL-8 and TNF production by cytokine and lipopolysaccharide-stimulated human renal cortical epithelial cells in vitro. |
1994 May-Jun |
Eur. Cytokine Netw. |
pmid:7524716
|
Yu L and Fesik SW |
pH titration of the histidine residues of cyclophilin and FK506 binding protein in the absence and presence of immunosuppressant ligands. |
1994 |
Biochim. Biophys. Acta |
pmid:7524680
|
Lepre CA et al. |
Solution structure of FK506 bound to the R42K, H87V double mutant of FKBP-12. |
1994 |
Biochemistry |
pmid:7524662
|
Bierer BE |
Cyclosporin A, FK506, and rapamycin: binding to immunophilins and biological action. |
1994 |
Chem. Immunol. |
pmid:7524531
|
Burnett D et al. |
Inhibition by FK506 of formyl peptide-induced neutrophil activation and associated protein synthesis. |
1994 |
Biochem. Pharmacol. |
pmid:7524504
|
Przepiorka D et al. |
Blood tacrolimus concentration unchanged by plasmapheresis. |
1994 |
Am J Hosp Pharm |
pmid:7524318
|
|
Tacrolimus introduced for use in liver transplantation. |
1994 |
Am J Hosp Pharm |
pmid:7524317
|
Fung JJ and Starzl TE |
FK 506 in solid organ transplantation. |
1994 |
Transplant. Proc. |
pmid:7524226
|
Kattner A et al. |
Conversion from CyA to CyA-NOF in a cholestatic liver grafted patient with CyA malabsorption. |
1994 |
Transplant. Proc. |
pmid:7524225
|
Kupferman JC et al. |
Activation of the renal renin-angiotensin system by cyclosporine A and FK 506 in the rat. |
1994 |
Transplant. Proc. |
pmid:7524224
|
Yoshimura R et al. |
Effect of immunosuppressive drugs (CsA, FK 506, rapamycin) on the kidney microsomal cytochrome P-450 system in the rat. |
1994 |
Transplant. Proc. |
pmid:7524223
|
Heitman J et al. |
Antifungal effects of cyclosporine and FK 506 are mediated via immunophilin-dependent calcineurin inhibition. |
1994 |
Transplant. Proc. |
pmid:7524220
|
Takahara S et al. |
Clinical evaluation of trough levels and area under the curve in cyclosporine- and FK 506-treated kidney transplant recipients. |
1994 |
Transplant. Proc. |
pmid:7524219
|
Singh N et al. |
Infectious complications in liver transplant recipients on tacrolimus. Prospective analysis of 88 consecutive liver transplants. |
1994 |
Transplantation |
pmid:7524204
|
Steinmüller TM et al. |
The effect of FK506 versus cyclosporine on glucose and lipid metabolism--a randomized trial. |
1994 |
Transplantation |
pmid:7524203
|
Apanay DC et al. |
Cyclosporine increases the oxidizability of low-density lipoproteins in renal transplant recipients. |
1994 |
Transplantation |
pmid:7524202
|
|
FDA approved new drug bulletin: aprotinin injection (trasylol), tacrolimus (prograf). |
1994 |
RN |
pmid:7524131
|
Perotti BY et al. |
HPLC assay for FK 506 and two metabolites in isolated rat hepatocytes and rat liver microsomes. |
1994 |
Pharm. Res. |
pmid:7524055
|
Schleuning M et al. |
Inhibition of cyclosporin A/FK506 resistant, lymphokine-induced T-cell activation by phenothiazine derivatives. |
1994 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:7523957
|
Calne RY |
Immunosuppression in liver transplantation. |
1994 |
N. Engl. J. Med. |
pmid:7523947
|
|
A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation. The U.S. Multicenter FK506 Liver Study Group. |
1994 |
N. Engl. J. Med. |
pmid:7523946
|
Schmidt A et al. |
Two FK506 resistance-conferring genes in Saccharomyces cerevisiae, TAT1 and TAT2, encode amino acid permeases mediating tyrosine and tryptophan uptake. |
1994 |
Mol. Cell. Biol. |
pmid:7523855
|
Collins RH |
Tacrolimus (FK506) versus cyclosporin in prevention of liver allograft rejection. |
1994 |
Lancet |
pmid:7523807
|
Krentz AJ et al. |
Tacrolimus (FK506) versus cyclosporin in prevention of liver allograft rejection. |
1994 |
Lancet |
pmid:7523806
|
Moore R and Lord R |
Tacrolimus (FK506) versus cyclosporin in prevention of liver allograft rejection. |
1994 |
Lancet |
pmid:7523805
|
Ohtomo Y et al. |
Coexisting NPY and NE synergistically regulate renal tubular Na+, K(+)-ATPase activity. |
1994 |
Kidney Int. |
pmid:7523751
|
Hiromura K et al. |
FK506 inhibits renal glomerular thrombosis induced in rats by nephrotoxic serum and lipopolysaccharide. |
1994 |
Kidney Int. |
pmid:7523750
|
Karmann K et al. |
Endothelial cell-induced resistance to cyclosporin A in human peripheral blood T cells requires contact-dependent interactions involving CD2 but not CD28. |
1994 |
J. Immunol. |
pmid:7523510
|
Clipstone NA et al. |
Molecular analysis of the interaction of calcineurin with drug-immunophilin complexes. |
1994 |
J. Biol. Chem. |
pmid:7523407
|
Kay AB |
Immunosuppressive agents in chronic severe asthma. |
1994 May-Jun |
Allergy Proc |
pmid:7523242
|
Ahern GP et al. |
Single channel activity of the ryanodine receptor calcium release channel is modulated by FK-506. |
1994 |
FEBS Lett. |
pmid:7523191
|
Hakamata Y et al. |
Involvement of the brain type of ryanodine receptor in T-cell proliferation. |
1994 |
FEBS Lett. |
pmid:7523185
|
Schmidt B et al. |
A homodimer represents an active species of the peptidyl-prolyl cis/trans isomerase FKBP25mem from Legionella pneumophila. |
1994 |
FEBS Lett. |
pmid:7523184
|
Pai SY et al. |
Cross-linking CD28 leads to activation of 70-kDa S6 kinase. |
1994 |
Eur. J. Immunol. |
pmid:7523138
|
Moia LJ et al. |
Immunosuppressants and calcineurin inhibitors, cyclosporin A and FK506, reversibly inhibit epileptogenesis in amygdaloid kindled rat. |
1994 |
Brain Res. |
pmid:7522929
|
Shapiro R et al. |
Improving results of pediatric renal transplantation. |
1994 |
J. Am. Coll. Surg. |
pmid:7522851
|
Abu-Elmagd K et al. |
Three years clinical experience with intestinal transplantation. |
1994 |
J. Am. Coll. Surg. |
pmid:7522850
|
Mouzaki A and Rungger D |
Properties of transcription factors regulating interleukin-2 gene transcription through the NFAT binding site in untreated or drug-treated naive and memory T-helper cells. |
1994 |
Blood |
pmid:7522636
|
Abu-Elmagd K et al. |
Recent advances in hepatic transplantation at the University of Pittsburgh. |
1993 |
Clin Transpl |
pmid:7522528
|
Lebeau MC et al. |
Rabbit FKBP-59/HBI does not inhibit calcineurin activity in vitro. |
1994 |
Biochem. Biophys. Res. Commun. |
pmid:7522447
|
Todo S et al. |
Single-center experience with primary orthotopic liver transplantation with FK 506 immunosuppression. |
1994 |
Ann. Surg. |
pmid:7522431
|
Devlin J et al. |
Nitric oxide generation. A predictive parameter of acute allograft rejection. |
1994 |
Transplantation |
pmid:7522365
|
Tanaka A et al. |
Living related liver transplantation across ABO blood groups. |
1994 |
Transplantation |
pmid:7522363
|
Bram RJ and Crabtree GR |
Calcium signalling in T cells stimulated by a cyclophilin B-binding protein. |
1994 |
Nature |
pmid:7522304
|
Sharkey J and Butcher SP |
Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischaemia. |
1994 |
Nature |
pmid:7522303
|
Nakagawa H et al. |
Tacrolimus ointment for atopic dermatitis. |
1994 |
Lancet |
pmid:7522297
|
Nichols RA et al. |
Calcineurin-mediated protein dephosphorylation in brain nerve terminals regulates the release of glutamate. |
1994 |
J. Biol. Chem. |
pmid:7522234
|
Metcalfe S et al. |
FK506 and cyclosporin A each inhibit antigen-specific signaling in the T cell line 171 in the absence of a calcium signal. |
1994 |
Cell. Immunol. |
pmid:7522130
|
Jung-Testas I et al. |
[Inhibition of the anti-glucocorticosteroid effect of RU486 on the growth of mouse fibroblasts in culture by the immunosuppressor kf506]]. |
1993 |
C. R. Acad. Sci. III, Sci. Vie |
pmid:7522119
|
Renoir JM et al. |
Immunological identification of a 50 kDa Mr FK506-binding immunophilin as a component of the non-DNA binding, hsp90 and hsp70 containing, heterooligomeric form of the chick oviduct progesterone receptor. |
1993 |
C. R. Acad. Sci. III, Sci. Vie |
pmid:7522118
|
D'Ambrosio R et al. |
Multicenter comparison of tacrolimus (FK 506) whole blood concentrations as measured by the Abbott IMX analyzer and enzyme immunoassay with methylene chloride extraction. |
1994 |
Ther Drug Monit |
pmid:7521979
|
Winkler M et al. |
Comparison of different assays for the quantitation of FK 506 levels in blood or plasma. |
1994 |
Ther Drug Monit |
pmid:7521978
|
Jensen C et al. |
Interaction between tacrolimus and erythromycin. |
1994 |
Lancet |
pmid:7521928
|
Krentz AJ et al. |
Serum lipids and apolipoproteins in liver transplant recipients: a comparative study of cyclosporin A and FK 506. |
1994 |
J. Lab. Clin. Med. |
pmid:7521895
|